Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Operating Margin (2017 - 2022)

Acro Biomedical (ACBM) has 6 years of Operating Margin data on record, last reported at 1092.75% in Q4 2022.

  • For Q4 2022, Operating Margin fell 146473.0% year-over-year to 1092.75%; the TTM value through Sep 2023 reached 3533.57%, down 245031.0%, while the annual FY2022 figure was 2409.98%, 227499.0% down from the prior year.
  • Operating Margin reached 1092.75% in Q4 2022 per ACBM's latest filing, up from 1316.11% in the prior quarter.
  • Across five years, Operating Margin topped out at 22509.27% in Q3 2019 and bottomed at 1316.11% in Q1 2022.
  • Average Operating Margin over 5 years is 1690.63%, with a median of 5.75% recorded in 2018.
  • Peak YoY movement for Operating Margin: skyrocketed 2250257bps in 2019, then plummeted -146473bps in 2022.
  • A 5-year view of Operating Margin shows it stood at 6.96% in 2018, then surged by 193bps to 6.5% in 2019, then soared by 82bps to 11.85% in 2020, then skyrocketed by 3038bps to 371.98% in 2021, then crashed by -394bps to 1092.75% in 2022.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 1092.75% in Q4 2022, 1316.11% in Q1 2022, and 371.98% in Q4 2021.